There are countless effective substances that could be used as highly efficient drugs – but these cannot be processed into drugs using typical drug formulations.
One major hurdle is the limited number of excipients, such as polymers, that can be used to manufacture the drugs. The production of new pharmaceutical polymers is the declared goal of “Next Generation Pharma Polymers” – NGP Polymers GmbH.
The start-up company produces novel pharma polymers under GMP-like conditions in order to use drug formulations with improved properties in the future.
NGP Polymers synthesizes pharmaceutical polymers from milligram to kilogram scale.
Particular focus is placed on synthesis under GMP conditions to generate timely pharmaceutical polymers that can be used directly for drug formulation. A particular specialty is the synthesis of polyoxazoline-based pharmaceutical polymers.
NGP Pharma Polymers
CEOs Dr. Stephanie Schubert & Dr. Georg Hochwimmer